{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:32:30Z","timestamp":1773923550952,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":1760,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.fertnstert.2017.06.011","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T19:45:37Z","timestamp":1499543137000},"page":"222-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Treatments for opioid use disorder among pregnant and reproductive-aged women"],"prefix":"10.1016","volume":"108","author":[{"given":"Dennis J.","family":"Hand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa L.","family":"Short","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane J.","family":"Abatemarco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2017.06.011_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2014.07.007","article-title":"Recent trends in treatment admissions for prescription opioid abuse during pregnancy","volume":"48","author":"Martin","year":"2015","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jama.1965.03090080008002","article-title":"A medical treatment for diacetylmorphine (heroin) addiction: a clinical trial with methadone hydrochloride","volume":"193","author":"Dole","year":"1965","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib3","series-title":"The effectiveness of methadone treatment: patients, programs, services, and outcome","author":"Ball","year":"1991"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib4","series-title":"The ASAM criteria: treatment criteria for addictive, substance-related, and co-occurring conditions","year":"2013"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0889-8545(05)70362-4","article-title":"Opioid dependence during pregnancy: effects and management","volume":"25","author":"Kaltenbach","year":"1998","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"J Addict Med"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib7","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e318256496e","article-title":"ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy","volume":"119","author":"ACOG Committee on Health Care for Underserved Women","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib8","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib9","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/add.13462","article-title":"Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child","volume":"111","author":"Zedler","year":"2016","journal-title":"Addict Abingdon Engl"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib10","doi-asserted-by":"crossref","first-page":"e547","DOI":"10.1542\/peds.2013-3524","article-title":"Neonatal abstinence syndrome","volume":"134","author":"Kocherlakota","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib11","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000\u20132009","volume":"307","author":"Patrick","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib12","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1056\/NEJMsa1500439","article-title":"Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs","volume":"372","author":"Tolia","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/jp.2015.63","article-title":"Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012","volume":"35","author":"Patrick","year":"2015","journal-title":"J Perinatol"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5055\/jom.2009.0006","article-title":"The opioid-exposed newborn: assessment and pharmacologic management","volume":"5","author":"Jansson","year":"2009","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib15","doi-asserted-by":"crossref","first-page":"e20152929","DOI":"10.1542\/peds.2015-2929","article-title":"Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost","volume":"137","author":"Holmes","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/jmwh.12009","article-title":"Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy","volume":"58","author":"O'Connor","year":"2013","journal-title":"J Midwifery Womens Health"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib17","doi-asserted-by":"crossref","first-page":"e1163","DOI":"10.1542\/peds.2005-1561","article-title":"Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers","volume":"117","author":"Abdel-Latif","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.drugalcdep.2012.11.019","article-title":"Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes","volume":"131","author":"Jones","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib19","doi-asserted-by":"crossref","first-page":"396.e1","DOI":"10.1016\/j.ajog.2008.06.088","article-title":"Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates","volume":"199","author":"Seligman","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib20","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2013.3411","article-title":"Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome","volume":"309","author":"Wachman","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib21","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/j.1360-0443.2010.03120.x","article-title":"Methadone dose and neonatal abstinence syndrome\u2014systematic review and meta-analysis","volume":"105","author":"Cleary","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1067\/S0002-9378(03)00520-9","article-title":"Maternal methadone dose and neonatal withdrawal","volume":"189","author":"Berghella","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib23","doi-asserted-by":"crossref","first-page":"374.e1","DOI":"10.1016\/j.ajog.2016.03.015","article-title":"Detoxification from opiate drugs during pregnancy","volume":"215","author":"Bell","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/ADM.0000000000000289","article-title":"Medically assisted withdrawal (detoxification): considering the mother-infant dyad","volume":"11","author":"Jones","year":"2017","journal-title":"J Addict Med"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.drugalcdep.2009.07.001","article-title":"Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument","volume":"105","author":"Tompkins","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib26","first-page":"CD003409","article-title":"Methadone at tapered doses for the management of opioid withdrawal","volume":"2","author":"Amato","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archpsyc.1977.01770150119014","article-title":"Withdrawal from methadone maintenance: rate of withdrawal and expectation","volume":"34","author":"Senay","year":"1977","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2011.05.033","article-title":"The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review","volume":"119","author":"Dunn","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib29","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jamapsychiatry.2013.2216","article-title":"A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers","volume":"70","author":"Sigmon","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib30","first-page":"CD002025","article-title":"Buprenorphine for managing opioid withdrawal","volume":"2","author":"Gowing","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib31","first-page":"CD002024","article-title":"Alpha2-adrenergic agonists for the management of opioid withdrawal","volume":"5","author":"Gowing","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib32","first-page":"176","article-title":"Lapse and relapse following inpatient treatment of opiate dependence","volume":"103","author":"Smyth","year":"2010","journal-title":"Ir Med J"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib33","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0006-3223(94)91240-8","article-title":"The efficacy of naltrexone in preventing reabuse of heroin after detoxification","volume":"35","author":"Shufman","year":"1994","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib34","first-page":"42","article-title":"Clinical experience with naltrexone in suburban opioid addicts","volume":"45","author":"Tennant","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib35","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archpsyc.63.2.210","article-title":"Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial","volume":"63","author":"Comer","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib36","doi-asserted-by":"crossref","first-page":"326.e1","DOI":"10.1016\/j.ajog.2009.05.052","article-title":"Risk factors for preterm birth among opiate-addicted gravid women in a methadone treatment program","volume":"201","author":"Almario","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2017.06.011_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1360-0443.2012.04042.x","article-title":"Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine","volume":"107","author":"Holbrook","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ypmed.2015.04.008","article-title":"Contraceptive use and method choice among women with opioid and other substance use disorders: a systematic review","volume":"80","author":"Terplan","year":"2015","journal-title":"Prev Med"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1440-1746.2000.02060.x","article-title":"Hepatitis C in injecting drug-using women during and after pregnancy","volume":"15","author":"Latt","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib40","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/ntr\/nts274","article-title":"A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine","volume":"15","author":"Chisolm","year":"2013","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/00952990903125235","article-title":"Smoking in pregnant women screened for an opioid agonist medication study compared to related pregnant and non-pregnant patient samples","volume":"35","author":"Jones","year":"2009","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jsat.2017.01.011","article-title":"Substance use, treatment, and demographic characteristics of pregnant women entering treatment for opioid use disorder differ by United States census region","volume":"76","author":"Hand","year":"2017","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib43","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000216466","article-title":"Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers: implications for treatment","volume":"15","author":"Winklbaur","year":"2009","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib44","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/j.1360-0443.2012.03844.x","article-title":"Methadone and perinatal outcomes: a prospective cohort study","volume":"107","author":"Cleary","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib45","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1197\/j.aem.2005.12.011","article-title":"Testing positive for methadone and either a tricyclic antidepressant or a benzodiazepine is associated with an accidental overdose death: analysis of medical examiner data","volume":"13","author":"Chan","year":"2006","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.drugalcdep.2014.02.014","article-title":"Comparison of toxicity associated with nonmedical use of benzodiazepines with buprenorphine or methadone","volume":"138","author":"Lee","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib47","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMsa1506575","article-title":"Declines in unintended pregnancy in the United States, 2008\u20132011","volume":"374","author":"Finer","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib48","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jsat.2010.08.011","article-title":"Unintended pregnancy in opioid-abusing women","volume":"40","author":"Heil","year":"2011","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib49","first-page":"65","article-title":"Reproductive health needs: comparing women at high, drug-related risk of HIV with a national sample","volume":"54","author":"Armstrong","year":"1999","journal-title":"J Am Med Womens Assoc (1972)"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib50","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2307\/2135777","article-title":"Barriers to family planning services among patients in drug treatment programs","volume":"23","author":"Armstrong","year":"1991","journal-title":"Fam Plann Perspect"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib51","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ypmed.2016.06.023","article-title":"Using behavioral economic theory to increase use of effective contraceptives among opioid-maintained women at risk of unintended pregnancy","volume":"92","author":"Heil","year":"2016","journal-title":"Prev Med"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib52","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3109\/10826089909039410","article-title":"Program quality effects on patient outcomes during methadone maintenance: a study of 17 clinics","volume":"34","author":"Magura","year":"1999","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib53","unstructured":"Price A, Simmel C. Partners' influence on women's addiction and recovery: the connection between substance abuse, trauma and intimate relationships. Berkeley: National Abandoned Infants Assistance Resource Center, University of California at Berkeley. 2002. Available at: https:\/\/pdfs.semanticscholar.org\/5de6\/5b487889a4f2fa1a54b348347144fdf9057e.pdf."},{"key":"10.1016\/j.fertnstert.2017.06.011_bib54","series-title":"SAMHA's concept of trauma and guidance for a trauma-informed approach. HHS Publication No. (SMA) 14\u20134884","author":"Substance Abuse and Mental Health Services Administration","year":"2014"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib55","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s10995-016-2244-1","article-title":"Reducing stress among mothers in drug treatment: a description of a mindfulness based parenting intervention","volume":"21","author":"Short","year":"2017","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib56","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0740-5472(02)00220-9","article-title":"The relationship between sexual and physical abuse and substance abuse consequences","volume":"22","author":"Liebschutz","year":"2002","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib57","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jsat.2007.01.010","article-title":"The impact of early trauma and abuse on residential substance abuse treatment outcomes for women","volume":"34","author":"Sacks","year":"2008","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib58","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1300\/J020v18n03_03","article-title":"Childhood trauma and drug addiction: assessment, diagnosis, and treatment","volume":"18","author":"Bernstein","year":"2000","journal-title":"Alcohol Treat Q"},{"issue":"Suppl 2","key":"10.1016\/j.fertnstert.2017.06.011_bib59","first-page":"1","article-title":"Prenatal substance use: exploring assumptions of maternal unfitness","volume":"9","author":"Terplan","year":"2015","journal-title":"Subst Abuse Res Treat"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archpsyc.1997.01830130077015","article-title":"Psychiatric and substance use comorbidity among treatment-seeking opioid abusers","volume":"54","author":"Brooner","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib61","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.drugalcdep.2003.11.014","article-title":"Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program","volume":"74","author":"Kidorf","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13722-017-0074-0","article-title":"The association between age of onset of opioid use and comorbidity among opioid dependent patients receiving methadone maintenance therapy","volume":"12","author":"Naji","year":"2017","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib63","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0740-5472(95)00025-Z","article-title":"Post-traumatic stress disorder among inner city methadone maintenance patients","volume":"12","author":"Villag\u00f3mez","year":"1995","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib64","series-title":"Methadone maintenance treatment and other opioid replacement therapies","first-page":"419","article-title":"Psychiatric comorbidity among the opioid dependent","author":"Ward","year":"1998"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib65","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0145-2134(95)00144-1","article-title":"Onset of physical abuse and neglect: psychiatric, substance abuse, and social risk factors from prospective community data","volume":"20","author":"Chaffin","year":"1996","journal-title":"Child Abuse Negl"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib66","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jsat.2004.06.008","article-title":"Rethinking parenting interventions for drug-dependent mothers: from behavior management to fostering emotional bonds","volume":"27","author":"Suchman","year":"2004","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib67","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1207\/S15327922PAR0104_2","article-title":"The mediating role of parenting stress in methadone-maintained mothers' parenting","volume":"1","author":"Suchman","year":"2001","journal-title":"Parent Sci Pract"},{"key":"10.1016\/j.fertnstert.2017.06.011_bib68","unstructured":"American Society of Addiction Medicine. Substance use, misuse, and use disorders during and following pregnancy, with an emphasis on opioids. Policy statement. January 18, 2017. Available at: http:\/\/www.asam.org\/advocacy\/find-a-policy-statement\/view-policy-statement\/public-policy-statements\/2017\/01\/19\/substance-use-misuse-and-use-disorders-during-and-following-pregnancy-with-an-emphasis-on-opioids."}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028217304351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028217304351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T20:33:37Z","timestamp":1663965217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028217304351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0015028217304351"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2017.06.011","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatments for opioid use disorder among pregnant and reproductive-aged women","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2017.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92017 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}